UniProtKB/Swiss-Prot Q15762: Variant p.Ser307Gly

CD226 antigen
Gene: CD226
Feedback?

Variant information Variant position:

307 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Serine (S) to Glycine (G) at position 307 (S307G, p.Ser307Gly). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from small size and polar (S) to glycine (G) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs763361 [ dbSNP | Ensembl ]

Sequence information Variant position:

307 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

336 The length of the canonical sequence.
Location on the sequence:

FTESWDTQKAPNNYRSPIST S QPTNQSMDDTREDIYVNYPT The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         FTESWDTQ-KAPNNYRSPISTSQPTNQSMDDTREDIYVNYPT

Rhesus macaque                YTESWDTQ-KAPKNYRSPISASQPTNQSMDDTREDIYVNYP

Mouse                         LKEPRDKQSKVATNCRSPTSPIQST----DDEKEDIYVNYP

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	19 – 336	CD226 antigen
Topological domain	276 – 336	Cytoplasmic
Region	297 – 316	Disordered
Modified residue	322 – 322	Phosphotyrosine

Literature citations
DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes.
Shibuya A.; Campbell D.; Hannum C.; Yssel H.; Franz-Bacon K.; McClanahan T.; Kitamura T.; Nicholl J.; Sutherland G.R.; Lanier L.L.; Phillips J.H.;
Immunity 4:573-581(1996)
Cited for: NUCLEOTIDE SEQUENCE [MRNA]; PROTEIN SEQUENCE OF 19-39; 54-72; 204-221 AND 285-294; FUNCTION; PHOSPHORYLATION; GLYCOSYLATION; TISSUE SPECIFICITY; VARIANT GLY-307; Receptor involved in the NK cell triggering.
Biassoni R.;
Cited for: NUCLEOTIDE SEQUENCE [MRNA]; VARIANT GLY-307; The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
The MGC Project Team;
Genome Res. 14:2121-2127(2004)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]; VARIANT GLY-307; Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.
Mayya V.; Lundgren D.H.; Hwang S.-I.; Rezaul K.; Wu L.; Eng J.K.; Rodionov V.; Han D.K.;
Sci. Signal. 2:RA46-RA46(2009)
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-322; VARIANT [LARGE SCALE ANALYSIS] GLY-307; IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS];

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.